chr16-71626551-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052858.6(MARVELD3):c.322G>A(p.Glu108Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000342 in 1,549,004 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052858.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MARVELD3 | NM_052858.6 | c.322G>A | p.Glu108Lys | missense_variant | 1/3 | ENST00000268485.8 | |
MARVELD3 | NM_001017967.4 | c.322G>A | p.Glu108Lys | missense_variant | 1/3 | ||
MARVELD3 | XM_011523449.4 | c.322G>A | p.Glu108Lys | missense_variant | 1/3 | ||
MARVELD3 | NM_001271329.2 | c.304+18G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MARVELD3 | ENST00000268485.8 | c.322G>A | p.Glu108Lys | missense_variant | 1/3 | 1 | NM_052858.6 | P2 | |
ENST00000562763.1 | n.219+47C>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000486 AC: 74AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000232 AC: 34AN: 146854Hom.: 0 AF XY: 0.000241 AC XY: 19AN XY: 78772
GnomAD4 exome AF: 0.000326 AC: 456AN: 1396762Hom.: 1 Cov.: 34 AF XY: 0.000344 AC XY: 237AN XY: 688968
GnomAD4 genome AF: 0.000486 AC: 74AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74436
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2022 | The c.322G>A (p.E108K) alteration is located in exon 1 (coding exon 1) of the MARVELD3 gene. This alteration results from a G to A substitution at nucleotide position 322, causing the glutamic acid (E) at amino acid position 108 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at